Page last updated: 2024-08-21

vancomycin and Parkinson Disease

vancomycin has been researched along with Parkinson Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Cheng, L; Cui, C; Hong, H; Hong, Y; Li, CS; Niu, GY; Qiao, CM; Quan, W; Shen, YQ; Shi, Y; Wu, J; Wu, YB; Zhao, LP; Zhao, WJ; Zhou, Y1
Kopell, BH; Rasouli, JJ1
Avendaño-Cantos, EM; Celis-Sánchez, J; Gálvez-Martínez, J; González Del Valle, F; López-Arroquia, E; Mesa-Varona, D1

Other Studies

3 other study(ies) available for vancomycin and Parkinson Disease

ArticleYear
Vancomycin Pretreatment on MPTP-Induced Parkinson's Disease Mice Exerts Neuroprotection by Suppressing Inflammation Both in Brain and Gut.
    Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2023, Volume: 18, Issue:1-2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Disease Models, Animal; Dopamine; Inflammation; Mice; Mice, Inbred C57BL; Myeloid Differentiation Factor 88; Neuroprotection; Neuroprotective Agents; NF-kappa B; Parkinson Disease; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; Vancomycin

2023
The Adjunctive Use of Vancomycin Powder Appears Safe and May Reduce the Incidence of Surgical-Site Infections After Deep Brain Stimulation Surgery.
    World neurosurgery, 2016, Volume: 95

    Topics: Administration, Topical; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Burkholderia cepacia; Burkholderia Infections; Cefuroxime; Deep Brain Stimulation; Device Removal; Doxycycline; Dystonia; Humans; Incidence; Intraoperative Care; Male; Middle Aged; Neurosurgical Procedures; Parkinson Disease; Powders; Prosthesis Implantation; Prosthesis-Related Infections; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Vancomycin

2016
[Corneal toxicity due to amantadine].
    Archivos de la Sociedad Espanola de Oftalmologia, 2012, Volume: 87, Issue:9

    Topics: Acyclovir; Amantadine; Antiparkinson Agents; Aqueous Humor; Cataract Extraction; Ceftazidime; Corneal Edema; Corneal Endothelial Cell Loss; Corneal Opacity; Diagnostic Errors; Female; Humans; Keratitis; Middle Aged; Parkinson Disease; Postoperative Complications; Prednisolone; Saline Solution, Hypertonic; Vancomycin

2012